TY - JOUR
T1 - Ocular side effects possibly associated with isotretinoin usage
AU - Fraunfelder, F. T.
AU - Fraunfelder, F. W.
AU - Edwards, Ralph
N1 - Funding Information:
This study was supported, in part, by an unrestricted grant from Research to Prevent Blindness, New York, New York.
PY - 2001
Y1 - 2001
N2 - PURPOSE: To evaluate reported ocular side effects associated with isotretinoin usage. METHODS: One thousand seven hundred forty-one case reports received from spontaneous reporting systems, data from the Drug Safety Section of Roche Pharmaceuticals, and the world's literature were evaluated using the World Health Organization Causality Assessment Guide of Suspected Adverse Reactions. RESULTS: Thirty-eight different signs or symptoms of ocular abnormalities associated with isotretinoin usage have been classified as 'certain,' 'probable/likely,' 'possible,' 'unlikely,' or 'conditional/unclassifiable.' CONCLUSION: Adverse ocular side effects secondary to isotretinoin that are 'certain' include abnormal meibomian gland secretion, blepharoconjunctivitis, corneal opacities, decreased dark adaptation, decreased tolerance to contact lens, decreased vision, increased tear osmolarity, keratitis, meibomian gland atrophy, myopia, ocular discomfort, ocular sicca, photophobia, and teratogenic ocular abnormalities. Those that are 'probable/likely' are decreased color vision (reversible) and permanent loss of dark adaptation. Those that have a 'possible' association include permanent keratoconjunctivitis sicca. Suggested guidelines for ocular examination for patients on isotretinoin are given.
AB - PURPOSE: To evaluate reported ocular side effects associated with isotretinoin usage. METHODS: One thousand seven hundred forty-one case reports received from spontaneous reporting systems, data from the Drug Safety Section of Roche Pharmaceuticals, and the world's literature were evaluated using the World Health Organization Causality Assessment Guide of Suspected Adverse Reactions. RESULTS: Thirty-eight different signs or symptoms of ocular abnormalities associated with isotretinoin usage have been classified as 'certain,' 'probable/likely,' 'possible,' 'unlikely,' or 'conditional/unclassifiable.' CONCLUSION: Adverse ocular side effects secondary to isotretinoin that are 'certain' include abnormal meibomian gland secretion, blepharoconjunctivitis, corneal opacities, decreased dark adaptation, decreased tolerance to contact lens, decreased vision, increased tear osmolarity, keratitis, meibomian gland atrophy, myopia, ocular discomfort, ocular sicca, photophobia, and teratogenic ocular abnormalities. Those that are 'probable/likely' are decreased color vision (reversible) and permanent loss of dark adaptation. Those that have a 'possible' association include permanent keratoconjunctivitis sicca. Suggested guidelines for ocular examination for patients on isotretinoin are given.
UR - http://www.scopus.com/inward/record.url?scp=0034887345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034887345&partnerID=8YFLogxK
U2 - 10.1016/S0002-9394(01)01024-8
DO - 10.1016/S0002-9394(01)01024-8
M3 - Article
C2 - 11530040
AN - SCOPUS:0034887345
SN - 0002-9394
VL - 132
SP - 299
EP - 305
JO - American journal of ophthalmology
JF - American journal of ophthalmology
IS - 3
ER -